In the frontal and parietal cortex of patients with AD, 43–55 distinct phosphorylation, 19 acetylation, 14–17 ubiquitination, and 4 methylation sites of tau have been identified (Wesseling et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.